Acutely inhaled iloprost improves right ventricular function in terms of RV volume, right ventricular ejection fraction, and RV stroke volume in patients with IPAH and PAH associated with connective tissue disease.
Adverse drug events associated with sulfasalazine are likely responsible for lower persistence and adherence rates in patients with RA initiating triple therapy compared with combination therapy.
Baricitinib has demonstrated an acceptable safety profile in adults with moderate to severe rheumatoid arthritis.
Patients with early arthritis may benefit from induction therapy with infliximab plus methotrexate.
Continued low disease activity in patients with rheumatoid arthritis is associated with atherosclerosis and heart dysfunction.
Exposure to passive smoking does not appear to increase the risk of developing rheumatoid arthritis.
Moderate- to high-intensity aerobic and resistance exercise improved physical fitness in older adults with rheumatoid arthritis.
Celecoxib demonstrated better overall gastrointestinal safety than ibuprofen or naproxen in patients with arthritis concurrently receiving esomeprazole and low-dose aspirin or corticosteroids.
The use of corticosteroids at doses of ≥5 mg/d was identified as a significant risk factor for herpes zoster development in patients with RA.
The dorsal 4-finger technique is a reliable method to examine metacarpophalangeal joints in rheumatoid arthritis.
